NCT00288392View on ClinicalTrials.gov

Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

September 30, 2006

Conditions
Foot Ulcer
Interventions
DRUG

Soluble beta-1,3/1,6-glucan

Trial Locations (2)

163061

Municipal Healthcare Institution 1st City Clinical Hospital, Arkhangelsk

195257

St. Petersburg State Institution Saint Martyr Elezabeth Hospital, Saint Petersburg

Sponsors
All Listed Sponsors
lead

Biotec Pharmacon ASA

INDUSTRY

NCT00288392 - Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients | Biotech Hunter | Biotech Hunter